Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

The Angels Initiative

Stroke prevention

  Alzheimer's Disease

  Free Subscription

Articles published in Am J Geriatr Psychiatry

Retrieve available abstracts of 50 articles:
HTML format

Single Articles

    May 2022
  1. TRAN D, Nguyen H, Pham T, Nguyen AT, et al
    Resources for Enhancing Alzheimer's Caregiver Health in Vietnam (REACH VN): Exploratory Analyses of Outcomes of a Cluster Randomized Controlled Trial to Test the Feasibility and Preliminary Efficacy of a Family Dementia Caregiver Intervention in Vietn
    Am J Geriatr Psychiatry. 2022 May 6. pii: S1064-7481(22)00400.
    PubMed     Abstract available

    Commentary on Agitation in Cognitive Disorders: Use of the National Alzheimer's Coordinating Center Uniform Data Set (NACC-UDS) to Evaluate International Psychogeriatric Association Definition.
    Am J Geriatr Psychiatry. 2022 May 5. pii: S1064-7481(22)00403.

  3. CAI S, Wang S, Yan D, Conwell Y, et al
    The Diagnosis of Schizophrenia Among Nursing Home Residents With ADRD: Does Race Matter?
    Am J Geriatr Psychiatry. 2022;30:636-646.
    PubMed     Abstract available

    April 2022
  4. SANO M, Zhu CW, Neugroschl J, Grossman HT, et al
    Agitation in Cognitive Disorders: Use of the National Alzheimer's Coordinating Center Uniform Data Set (NACC-UDS) to Evaluate International Psychogeriatric Association Definition.
    Am J Geriatr Psychiatry. 2022 Apr 21. pii: S1064-7481(22)00393.
    PubMed     Abstract available

    March 2022
  5. MORROW CB, Leoutsakos JS, Onyike CU
    Functional Disabilities and Psychiatric Symptoms in Primary Progressive Aphasia.
    Am J Geriatr Psychiatry. 2022;30:372-382.
    PubMed     Abstract available

    February 2022
  6. DONAGHY PC, Cockell SJ, Martin-Ruiz C, Coxhead J, et al
    Blood mRNA Expression in Alzheimer's Disease and Dementia With Lewy Bodies.
    Am J Geriatr Psychiatry. 2022 Feb 12. pii: S1064-7481(22)00264.
    PubMed     Abstract available

  7. SIMNING A, Orth J, Temkin-Greener H, Li Y, et al
    Skilled Nursing Facility-to-Home Trajectories for Older Adults With Mental Illness or Dementia.
    Am J Geriatr Psychiatry. 2022;30:223-234.
    PubMed     Abstract available

  8. BOYLE PA, Wang T, Yu L, Barnes LL, et al
    Purpose in Life May Delay Adverse Health Outcomes in Old Age.
    Am J Geriatr Psychiatry. 2022;30:174-181.
    PubMed     Abstract available

    January 2022
  9. AU-YEUNG WM, Miller L, Beattie Z, May R, et al
    Monitoring Behaviors of Patients With Late-Stage Dementia Using Passive Environmental Sensing Approaches: A Case Series.
    Am J Geriatr Psychiatry. 2022;30:1-11.
    PubMed     Abstract available

  10. WEINSTEIN AM, Gujral S, Butters MA, Bowie CR, et al
    Diagnostic Precision in the Detection of Mild Cognitive Impairment: A Comparison of Two Approaches.
    Am J Geriatr Psychiatry. 2022;30:54-64.
    PubMed     Abstract available

    July 2021
  11. MORTBY ME, Adler L, Aguera-Ortiz L, Bateman DR, et al
    Apathy as a Treatment Target in Alzheimer's Disease: Implications for Clinical Trials.
    Am J Geriatr Psychiatry. 2021 Jul 1. pii: S1064-7481(21)00380.
    PubMed     Abstract available

  12. TALASLAHTI T, Ginters M, Kautiainen H, Vataja R, et al
    Criminal Behavior in the Four Years Preceding Diagnosis of Neurocognitive Disorder: A Nationwide Register Study in Finland.
    Am J Geriatr Psychiatry. 2021;29:657-665.
    PubMed     Abstract available

    June 2021
  13. RAJKUMAR AP, Hye A, Lange J, Manesh YR, et al
    Next-Generation RNA-Sequencing of Serum Small Extracellular Vesicles Discovers Potential Diagnostic Biomarkers for Dementia With Lewy Bodies.
    Am J Geriatr Psychiatry. 2021;29:573-584.
    PubMed     Abstract available

    May 2021
  14. BURHANULLAH MH, Rosenberg P
    Low-Dose Lithium for Management of Neuropsychiatric Symptoms in Alzheimer Disease.
    Am J Geriatr Psychiatry. 2021 May 21. pii: S1064-7481(21)00324.

  15. DEVANAND DP, Crocco E, Forester BP, Husain MM, et al
    Low Dose Lithium Treatment of Behavioral Complications in Alzheimer's Disease: Lit-AD Randomized Clinical Trial.
    Am J Geriatr Psychiatry. 2021 May 12. pii: S1064-7481(21)00312.
    PubMed     Abstract available

  16. IRIARTE ES, Jimenez DE
    A Caregiver Must Be Healthy to Be Able to Care.
    Am J Geriatr Psychiatry. 2021;29:473-475.

    Are Medical Care Expenses Higher for Spouses Who Provide Dementia Care?
    Am J Geriatr Psychiatry. 2021;29:476-477.

  18. TAYLOR WD, Boyd BD, Elson D, Andrews P, et al
    Preliminary Evidence That Cortical Amyloid Burden Predicts Poor Response to Antidepressant Medication Treatment in Cognitively Intact Individuals With Late-Life Depression.
    Am J Geriatr Psychiatry. 2021;29:448-457.
    PubMed     Abstract available

    April 2021
  19. LEE YM, Park JM, Lee BD, Moon E, et al
    The Role of Decreased Cortical Thickness and Volume of Medial Temporal Lobe Structures in Predicting Incident Psychosis in Patients With Alzheimer's Disease: A Prospective Longitudinal MRI Study.
    Am J Geriatr Psychiatry. 2021 Apr 30. pii: S1064-7481(21)00313.
    PubMed     Abstract available

  20. CHAN NK, Gerretsen P, Chakravarty MM, Blumberger DM, et al
    Structural Brain Differences Between Cognitively Impaired Patients With and Without Apathy.
    Am J Geriatr Psychiatry. 2021;29:319-332.
    PubMed     Abstract available

    March 2021
    Commentary on "Cannabinoids for Agitation in Alzheimer's Disease".
    Am J Geriatr Psychiatry. 2021 Mar 19. pii: S1064-7481(21)00262.

    February 2021
  22. CHAN CK, Sieber FE, Blennow K, Inouye SK, et al
    Association of Depressive Symptoms With Postoperative Delirium and CSF Biomarkers for Alzheimer's Disease Among Hip Fracture Patients.
    Am J Geriatr Psychiatry. 2021 Feb 4. pii: S1064-7481(21)00166.
    PubMed     Abstract available

  23. KRELL-ROESCH J, Syrjanen JA, Vassilaki M, Lowe VJ, et al
    Brain Regional Glucose Metabolism, Neuropsychiatric Symptoms, and the Risk of Incident Mild Cognitive Impairment: The Mayo Clinic Study of Aging.
    Am J Geriatr Psychiatry. 2021;29:179-191.
    PubMed     Abstract available

    January 2021
  24. OUTEN JD, Burhanullah MH, Vandrey R, Amjad H, et al
    Cannabinoids for Agitation in Alzheimer's Disease.
    Am J Geriatr Psychiatry. 2021 Jan 27. pii: S1064-7481(21)00030.
    PubMed     Abstract available

  25. KIM D, Wang R, Kiss A, Bronskill SE, et al
    Depression and Increased Risk of Alzheimer's Dementia: Longitudinal Analyses of Modifiable Risk and Sex-Related Factors.
    Am J Geriatr Psychiatry. 2021 Jan 6. pii: S1064-7481(20)30600.
    PubMed     Abstract available

    Neurobiological Targets of Apathy Can Guide Treatment Development.
    Am J Geriatr Psychiatry. 2021;29:63-65.

    November 2020
    Late-Life Depression and Alzheimer's Disease Pathology: An Ounce of Prevention, a Pound of Cure.
    Am J Geriatr Psychiatry. 2020 Nov 28. pii: S1064-7481(20)30559.

    September 2020
  28. CHU J, Benjenk I, Chen J
    Incremental Health Care Expenditures of the Spouses of Older Adults With Alzheimer's Diseases and Related Dementias (ADRD).
    Am J Geriatr Psychiatry. 2020 Sep 30. pii: S1064-7481(20)30502.
    PubMed     Abstract available

  29. WEINBERG MS, Patrick RE, Schwab NA, Owoyemi P, et al
    Clinical Trials and Tribulations in the COVID-19 Era.
    Am J Geriatr Psychiatry. 2020;28:913-920.
    PubMed     Abstract available

    August 2020
  30. HAMILTON CA, Matthews FE, Donaghy PC, Taylor JP, et al
    Cognitive Decline in Mild Cognitive Impairment With Lewy Bodies or Alzheimer Disease: A Prospective Cohort Study.
    Am J Geriatr Psychiatry. 2020 Aug 8. pii: S1064-7481(20)30437.
    PubMed     Abstract available

    July 2020
  31. ORSO B, Mattei C, Arnaldi D, Massa F, et al
    Clinical and MRI Predictors of Conversion From Mild Behavioural Impairment to Dementia.
    Am J Geriatr Psychiatry. 2020;28:755-763.
    PubMed     Abstract available

    May 2020
  32. LANCTOT KL, Scherer RW, Li A, Vieira D, et al
    Measuring Apathy in Alzheimer's Disease in the Apathy in Dementia Methylphenidate Trial 2 (ADMET 2): A Comparison of Instruments.
    Am J Geriatr Psychiatry. 2020 May 27. pii: S1064-7481(20)30349.
    PubMed     Abstract available

  33. VAN DYCK CH, Arnsten AFT, Padala PR, Brawman-Mintzer O, et al
    Neurobiologic Rationale for Treatment of Apathy in Alzheimer's Disease With Methylphenidate.
    Am J Geriatr Psychiatry. 2020 May 5. pii: S1064-7481(20)30327.
    PubMed     Abstract available

  34. KEMP EC, Ebner MK, Ramanan S, Godek TA, et al
    Statin Use and Risk of Cognitive Decline in the ADNI Cohort.
    Am J Geriatr Psychiatry. 2020;28:507-517.
    PubMed     Abstract available

    April 2020
  35. ISAIA G, Marinello R, Tibaldi V, Tamone C, et al
    Atypical Presentation of Covid-19 in an Older Adult With Severe Alzheimer Disease.
    Am J Geriatr Psychiatry. 2020 Apr 22. pii: S1064-7481(20)30319.

  36. BROWN EE, Kumar S, Rajji TK, Pollock BG, et al
    Anticipating and Mitigating the Impact of the COVID-19 Pandemic on Alzheimer's Disease and Related Dementias.
    Am J Geriatr Psychiatry. 2020 Apr 18. pii: S1064-7481(20)30294.
    PubMed     Abstract available

  37. BEAUDREAU SA, Schneider L
    Commentary on "The Association Between Biomarkers and Neuropsychiatric Symptoms Across the Alzheimer's Disease Spectrum".
    Am J Geriatr Psychiatry. 2020 Apr 15. pii: S1064-7481(20)30291.

  38. ALMEIDA OP, Ford AH
    Are We Getting Better at Managing Agitation in Dementia?
    Am J Geriatr Psychiatry. 2020;28:401-403.

    March 2020
  39. CHEN CL, Liang CK, Yin CH, Lin YT, et al
    Corrigendum to 'Effects of Socioeconomic Status on Alzheimer Disease Mortality in Taiwan' [The American Journal of Geriatric Psychiatry 28 (2020) 205-216].
    Am J Geriatr Psychiatry. 2020 Mar 17. pii: S1064-7481(20)30256.

    February 2020
  40. BANNING LCP, Ramakers IHGB, Kohler S, Bron EE, et al
    The Association Between Biomarkers and Neuropsychiatric Symptoms Across the Alzheimer's Disease Spectrum.
    Am J Geriatr Psychiatry. 2020 Feb 19. pii: S1064-7481(20)30025.
    PubMed     Abstract available

  41. WEI S, Gao L, Jiang Y, Shang S, et al
    Apolipoprotein E epsilon4 Allele is Associated With Plasma Amyloid Beta and Amyloid Beta Transporter Levels: A Cross-sectional Study in a Rural Area of Xi'an, China.
    Am J Geriatr Psychiatry. 2020;28:194-204.
    PubMed     Abstract available

    January 2020
    Commentary: Lessons Learned From Animal Models for Schizophrenia.
    Am J Geriatr Psychiatry. 2020;28:20-22.

  43. TAN ECK, Johnell K, Bell JS, Garcia-Ptacek S, et al
    Do Acetylcholinesterase Inhibitors Prevent or Delay Psychotropic Prescribing in People With Dementia? Analyses of the Swedish Dementia Registry.
    Am J Geriatr Psychiatry. 2020;28:108-117.
    PubMed     Abstract available

  44. BURHANULLAH MH, Tschanz JT, Peters ME, Leoutsakos JM, et al
    Neuropsychiatric Symptoms as Risk Factors for Cognitive Decline in Clinically Normal Older Adults: The Cache County Study.
    Am J Geriatr Psychiatry. 2020;28:64-71.
    PubMed     Abstract available

    October 2019
  45. FORESTER BP, Rahman AT, Harper DG, Petrides G, et al
    Evolving Evidence for the Efficacy and Safety of ECT for Agitation in Alzheimer Disease.
    Am J Geriatr Psychiatry. 2019 Oct 24. pii: S1064-7481(19)30548.

  46. GROSSBERG GT, Kohegyi E, Mergel V, Josiassen MK, et al
    Efficacy and Safety of Brexpiprazole for the Treatment of Agitation in Alzheimer's Dementia: Two 12-Week, Randomized, Double-Blind, Placebo-Controlled Trials.
    Am J Geriatr Psychiatry. 2019 Oct 1. pii: S1064-7481(19)30521.
    PubMed     Abstract available

    August 2019
  47. CHAPMAN BP, Phillips C
    Financial Risk Aversion and Incipient Dementia.
    Am J Geriatr Psychiatry. 2019;27:862-864.

    April 2019
  48. VERMA M
    Reliably Assessing Language Function in Dementia in the 21st Century.
    Am J Geriatr Psychiatry. 2019;27:378-380.

  49. STARKSTEIN S, Hayhow B
    Apathy in Dementia: Time to StandUp.
    Am J Geriatr Psychiatry. 2019;27:406-407.

    March 2019
    Late-Life Depression and Lewy Body Disease.
    Am J Geriatr Psychiatry. 2019;27:287-289.

Thank you for your interest in scientific medicine.

AMEDEO Alzheimer's Disease is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.